Chang David D - Insider Non-Derivative Transactions at Allogene Therapeutics, Inc. (ALLO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 16, 2024, Chang David D's relationship to Allogene Therapeutics, Inc. (ALLO) is Director,Officer (President and CEO), and currently has 4,810,106 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ALLO insiders.
Data Source: SEC.
Chang David D - Insider Non-Derivative Transactions of ALLO Common Stock
Chang David D - Insider Non-Derivative Transactions at ALLO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 17, 2024 | Acquisition -- (Common Stock) | 344828 | 2.9 | 4810106 |
| Mar 15, 2024 | F -- (Common Stock) | 53393 | 4.33 | 4465278 |
| Jan 26, 2024 | Acquisition -- (Common Stock) | 317800 | 0 | 4513203 |
| Mar 23, 2023 | Acquisition -- (Common Stock) | 1924464 | 0 | 4193911 |
| Mar 15, 2023 | F -- (Common Stock) | 22340 | 5.56 | 2269447 |